Advertisement

Topics

BioMolecular Therapeutics Company Profile

01:46 EST 15th December 2018 | BioPortfolio

BMT elucidates modulation of host defense mechanisms responsible for inflammatory and autoimmune diseases. The major disease areas in which BMT is conducting research are atherosclerosis, rheumatoid arthritis and certain forms of allergies. With a staff of more than 50 researchers and initial € 12 million of corporate and public funding, BMT generates break-through innovations which can be turned into marketable intellectual property rights. BMT provides attractive new technologies which are ready for industrial applications and which have substantial spin-off potential.
As a joint venture between the industrial partners Baxter, Technoclone and Polymun and academic partners from the Medical University Vienna and the University of Natural Resources and Applied Life Sciences, Vienna, BMT not only receives substantial funding (in-kind and cash) from pharmaceutical industry, but also contributes from the intellectual power of outstanding scientists from renowned academic institutes.

Location

Brunner Strasse 59,
Vienna
Vienna
A-1230
Austria

Contact

Phone: 43.1.867.3691
Fax: 43.1.867.3694
Email: office@bmt-research.at


News Articles [719 Associated News Articles listed on BioPortfolio]

Centri-Sep, biotechnology, molecular separations, Panagel, electrophoresis, neuroscience

Leading,manufacturer,of,Centri-Sep,Plasmid-Prep,Panagel,Centri-Spin,Psi-Clone,used,in,DNA,sequencing,electrophoresis,biomolecular,purification

AAPS PharmSci 360 preview: ‘Small-conference feel and big-conference breadth’

AAPS PharmSci 360 is a new conference this year, created in response to a desire for âfresh science,â specifically with chemical and biomolecular components. So what can you expect?

Protein Crystals Used to Prepare Cellular Drug Delivery Nanotubes

A team of Japanese biomolecular engineers used scaffolds of cross-linked protein crystals to prepare nanotubes, which are structures that can...

Nanotubes Built From Protein Crystals: Breakthrough in Biomolecular Engineering

NewsResearchers have succeeded in constructing protein nanotubes from tiny scaffolds made by cross-linking of engineered protein crystals. C

UA professor receives NSF grant to develop antifouling materials for medical implants

Jie Zheng, Ph.D., a chemical and biomolecular engineering professor at The University of Akron, recently received a grant from the National Science Foundation for research that will focus on the devel...

P.V. Danckwerts Memorial Lecture awards distinguished Professor Lee

(The Korea Advanced Institute of Science and Technology (KAIST)) Distinguished Professor Sang Yup Lee from the Department of Chemical and Biomolecular Engineering was selected as the awardee of the 20...

M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin

Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this we...

Roche’s Genentech agrees to buy Jecure Therapeutics

Based in San Diego of California, Jecure Therapeutics is engaged in the discovery of therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure Therapeutics president and CE...

PubMed Articles [597 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Basics and applications of analytical molecular and biomolecular spectroscopy.

Biomolecular charges influence the response of surface plasmon resonance biosensors through electronic and ionic mechanisms.

Surface plasmon resonance (SPR) biosensors have become an important label-free optical biomolecular sensing technology and a "gold standard" for retrieving information on the kinetics of biomolecular ...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Clinical Trials [177 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1306 Associated Companies listed on BioPortfolio]

Centre for Molecular and Biomolecular Informatics

Welcome at the CMBI, which is short for Centre for Molecular and Biomolecular Informatics. The centre performs research and education, and provides services in bioinformatics and cheminformatics.

Association of Biomolecular Resource Facilities

The Association of Biomolecular Resource Facilities is an international society dedicated to advancing core and research biotechnology laboratories through research, communication, and education.

BioMolecular Therapeutics, Inc.

An early-stage biopharmaceutical company, BMT is pioneering the development of novel RNAi therapeutics to prevent and treat age-related macular degeneration based on the company's proprietary technolo...

Affigen

Affigen (www.affigen.com) develops tumor-identifying therapeutics that target cell lineage-specific tumor proteins in certain incurable cancers. The Company's growing team ...

Aquasome

A platform nanoparticulate technology for biomolecular delivery in a broad range of industrial, personal use, and biomedical applications.

More Information about "BioMolecular Therapeutics" on BioPortfolio

We have published hundreds of BioMolecular Therapeutics news stories on BioPortfolio along with dozens of BioMolecular Therapeutics Clinical Trials and PubMed Articles about BioMolecular Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMolecular Therapeutics Companies in our database. You can also find out about relevant BioMolecular Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record